Showing results (2141-2150 of 2,282) with videos related to

Sort By:
Pageof 229
Polymers|January 20, 2021
Synthesis and Application of Arylaminophosphazene as a Flame Retardant and Catalyst for the Polymerization of BenzoxazinesNatalia V Bornosuz, Irina Yu Gorbunova, Vyacheslav V Kireev, et al.
Biochimie|August 3, 2018
Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variantsNatalia V Mitiushkina, Vladislav I Tiurin, Aglaya G Iyevleva, et al.
Biology of the Cell|October 13, 2016
The integrative role of cryo electron microscopy in molecular and cellular structural biologyIgor Orlov, Alexander G Myasnikov, Leonid Andronov, et al.
Bioconjugate Chemistry|April 3, 2025
Choice of an Optimal Modular Strategy for the Synthesis of DOTA-Containing Heterobivalent Agents Targeting PSMA and GRPrStanislav A Petrov, Gleb P Grigoriev, Grigory A Orlov, et al.
Frontiers in Cellular and Infection Microbiology|November 16, 2020
Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor DrugsPavel M Kopeikin, Maria S Zharkova, Alexander A Kolobov, et al.
BMC Veterinary Research|December 11, 2020
Active surveillance for antibodies confirms circulation of lyssaviruses in Palearctic batsVeronika Seidlova, Jan Zukal, Jiri Brichta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2023
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical TrialEdward B Garon, Shun Lu, Yasushi Goto, et al.
Nature|October 19, 2010
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identityNa-Yu Chia, Yun-Shen Chan, Bo Feng, et al.
European Journal of Medicinal Chemistry|March 26, 2019
Compounds based on 5-(perylen-3-ylethynyl)uracil scaffold: High activity against tick-borne encephalitis virus and non-specific activity against enterovirus AAlexey A Chistov, Alexey A Orlov, Philipp P Streshnev, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2014
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesotheliomaL M Krug, A J Wozniak, H L Kindler, et al.
Pageof 229